Skip to main content

Client News

BioLizard Appoints Matthew Hall as Director of Business Development

18th April 2024

Newron announces AGM 2024 results

17th April 2024

CARBIOS Wins “So French So Innovative” Award at InnoEX 2024, Hong Kong, Recognizing French Innovation in Asia Pacific

16th April 2024

Convincing Overall Performance – Formycon Reports Preliminary Results for the Financial Year 2023 and Exceeds Forecast

15th April 2024

Syntekabio to Showcase Innovative AI Drug Discovery Technologies at Bio-IT World

11th April 2024

Lindis Blood Care to Present Top Line Results from Clinical Certification Study REMOVE with CATUVAB® at NATA24 Annual Symposium

11th April 2024

Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technolog

11th April 2024

CARBIOS Announces Fiscal-Year 2023 Financial Results and Confirms 2024 Calendar for Industrial and Commercial Roll-Out

11th April 2024

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

10th April 2024

CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth

10th April 2024